© by Wichtig Editore, 2001 0393-974X/068-011 $05.50 a significant increase in the number
of positive cells, due to various reasons, such as occurrence of nonspecific cross-reactivity …

BACKGROUND Although many studies have been performed to evaluate the prognostic
significance of CD34 expression in acute myeloid leukemia (AML), the findings have been …

In a recent issue of BLOOD, Yin et al1 reported the production of AC133, a monoclonal
antibody (MoAb) that binds to a novel cell surface antigen present on a CD34 (bright) subset …

Objectives This study focused on the expression pattern and clinical significance of B7-H3
expression in human acute leukemia. Methods We systematically analyzed 134 patients …

Primary resistance and relapses after initial successful treatment are common in acute
myeloid leukaemia and therefore outcome remains poor. More accurate risk group …

BACKGROUND AND OBJECTIVES: Altered expression of members of the Bcl-2 family might
account for the observed apoptosis resistance to chemotherapy in acute myeloid leukemia …

Resistance to chemotherapy-induced apoptosis and a multidrug-resistance (MDR)
phenotype, mainly mediated by P-glycoprotein (P-gp), contribute to chemotherapy failure in …

During a 10‐year period (1992–2001) in the region of Southern Denmark, 337 patients aged
15 years or older (range 16–93 years, median 67 years) were diagnosed with acute myeloid …

Background Acute myeloid leukemia (AML) is a heterogeneous disease with an overall poor
prognosis. Gene expression profiling studies of patients with AML has provided key insights …

The expression of adhesion molecules on CD34+ cells in acute myeloid leukemia (AML)
and B‐lineage acute lymphoblastic leukemia (B‐lineage ALL) was compared with that on …